logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

BEKE-W (02423) repurchased 537,500 shares for $2.983 million on December 1st.

date
19:44 02/12/2025
avatar
GMT Eight
Shell-W (02423) announced that on December 1, 2025, the company will spend $2.9883 million to repurchase 537,500 shares, at a repurchase price of $5.52-5.72 per share.
BEKE-W(02423) announced that on December 1, 2025, the company will spend 2.9883 million US dollars to repurchase 537,500 shares at a repurchase price of 5.52-5.72 US dollars per share.
Related Articles
HK Stock
MICROTECH MED-B(02235) spent HK$210,100 on December 2nd to repurchase 31,700 shares.
HK Stock
Shanghai Fosun Pharmaceutical (02196): The drug registration application for Sodium Chloride Injection has been accepted by the National Medical Products Administration.
China Stock
Fujian Acetron New Materials (300706.SZ) plans to raise funds through private placement of not more than 900 million yuan.
MICROTECH MED-B(02235) spent HK$210,100 on December 2nd to repurchase 31,700 shares.
HK Stock
Shanghai Fosun Pharmaceutical (02196): The drug registration application for Sodium Chloride Injection has been accepted by the National Medical Products Administration.
HK Stock
Fujian Acetron New Materials (300706.SZ) plans to raise funds through private placement of not more than 900 million yuan.
China Stock
RECOMMEND
In 2025, Investors No Longer Favor Beauty Brands
In 2025, Investors No Longer Favor Beauty Brands
icon
02/12/2025
Foreign Investment Giants Raise Forecasts, China Stocks “Overweight,” Technology And Consumption As Key Focus
Foreign Investment Giants Raise Forecasts, China Stocks “Overweight,” Technology And Consumption As Key Focus
icon
02/12/2025
Listing, “Encirclement,” And RMB 2.89 Billion Delivery Fees: Luckin Coffee Has No Way Back In 2025
Listing, “Encirclement,” And RMB 2.89 Billion Delivery Fees: Luckin Coffee Has No Way Back In 2025
icon
02/12/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.